EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
8.35
-0.61 (-6.76%)
Nov 21, 2024, 4:00 PM EST - Market closed
EyePoint Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 586 | 1,088 | 119 | 415 | 100 | 168 | |
| Market Cap Growth | 52.98% | 811.96% | -71.25% | 316.71% | -40.59% | -6.64% | |
| Enterprise Value | 355 | 958 | 8 | 334 | 125 | 186 | |
| Last Close Price | 8.35 | 23.11 | 3.50 | 12.24 | 6.58 | 15.50 | |
| PS Ratio | 9.26 | 23.64 | 2.88 | 11.23 | 2.89 | 8.23 | |
| PB Ratio | 2.04 | 4.08 | 1.24 | 2.25 | 5.37 | 20.12 | |
| P/TBV Ratio | 1.95 | 4.08 | 1.24 | 2.57 | - | - | |
| P/OCF Ratio | - | 580.20 | - | - | - | - | |
| EV/Sales Ratio | 7.77 | 20.82 | 0.20 | 9.05 | 3.62 | 9.14 | |
| Debt / Equity Ratio | 0.11 | 0.02 | 0.48 | 0.21 | 2.21 | 6.07 | |
| Asset Turnover | 0.20 | 0.17 | 0.19 | 0.21 | 0.42 | 0.27 | |
| Inventory Turnover | 29.85 | 20.32 | 17.83 | 8.06 | 6.22 | 14.94 | |
| Quick Ratio | 5.21 | 5.25 | 4.63 | 9.72 | 3.65 | 2.92 | |
| Current Ratio | 5.50 | 5.45 | 5.00 | 10.05 | 4.24 | 3.62 | |
| Return on Equity (ROE) | -74.68% | -39.04% | -72.84% | -57.58% | -337.87% | -247.12% | |
| Return on Assets (ROA) | -31.39% | -17.24% | -22.24% | -19.46% | -28.30% | -39.58% | |
| Return on Capital (ROIC) | -47.18% | -22.28% | -26.94% | -24.40% | -39.32% | -52.39% | |
| Earnings Yield | -17.68% | -6.51% | -85.72% | -14.08% | -45.60% | -33.89% | |
| FCF Yield | -20.15% | -0.15% | -56.30% | -12.11% | -14.86% | -33.96% | |
| Buyback Yield / Dilution | -34.50% | -4.25% | -29.76% | -124.04% | -23.06% | -53.88% | |
| Total Shareholder Return | -34.50% | -4.25% | -29.76% | -124.04% | -23.06% | -53.88% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.